Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Medicure Inc. stock logo
MPH
Medicure
C$1.18
+1.7%
C$0.96
C$0.63
C$1.26
C$12.32M0.94,221 shs2,506 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Medicure Inc. stock logo
MPH
Medicure
0.00%+11.32%+25.53%+32.58%+8.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Medicure Inc. stock logo
MPH
Medicure
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Medicure Inc. stock logo
MPH
Medicure
C$21.08M0.58C$0.47 per share2.49C$1.91 per share0.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Medicure Inc. stock logo
MPH
Medicure
-C$2.03M-C$0.19N/AN/A-9.65%-10.18%-5.63%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Medicure Inc. stock logo
MPH
Medicure
N/A2.24%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Medicure Inc. stock logo
MPH
Medicure
4.65
2.03
1.29

Institutional Ownership

CompanyInstitutional Ownership
Medicure Inc. stock logo
MPH
Medicure
23.10%

Insider Ownership

CompanyInsider Ownership
Medicure Inc. stock logo
MPH
Medicure
26.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.44 millionN/ANot Optionable

Recent News About These Companies

Medicure Inc. (NGQ1.F)
Medicure Inc. (MPH.V)
MPH:CA Medicure Inc.
Fastest Cars In The World Ranked

Media Sentiment Over Time

Top Headlines

View All Headlines
Medicure stock logo

Medicure CVE:MPH

C$1.18 +0.02 (+1.72%)
As of 06/20/2025 11:38 AM Eastern

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.